Topchoice Medical Co., Inc. (SHA:600763)

Topchoice Medical Co. Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Revenue	2,912	2,902	2,859	2,832	2,697	2,758
Other Revenue	11.29	11.29	14.6	14.51	21.21	22.23
Revenue	2,924	2,913	2,874	2,847	2,719	2,781
Revenue Growth (YoY)	0.47%	1.37%	0.96%	4.70%	-2.23%	33.18%
Cost of Revenue	1,796	1,788	1,767	1,750	1,609	1,500
Gross Profit	1,127	1,125	1,107	1,097	1,110	1,281
Selling, General & Admin	358.09	354.15	348.65	338.22	312.81	283.39
Research & Development	61.72	61.23	58.95	55.65	54.03	59.13
Other Operating Expenses	7.25	4.83	4.93	6.79	6.11	7.55
Operating Expenses	433.08	431.56	415.7	402.41	374.62	351.35
Operating Income	694.42	693.72	690.92	694.35	734.97	929.37
Interest Expense	-34.5	-35.85	-45.44	-55.01	-50.05	-28.91
Interest & Investment Income	45.78	48.39	50.52	71.82	47.54	67.79
Other Non Operating Income (Expenses)	-7.96	-7.67	-5.3	-8.37	-6	-2.77
EBT Excluding Unusual Items	697.74	698.6	690.71	702.78	726.46	965.49
Gain (Loss) on Sale of Investments	0.9	0.9	1.42	-	-	-
Gain (Loss) on Sale of Assets	-0.25	-0.27	0.14	-	-0.05	-0.02
Asset Writedown	-0.36	-0.36	-0.86	-0.42	-0.51	-0.21
Other Unusual Items	9.28	6.48	2.18	6.46	12.08	9.33
Pretax Income	707.31	705.36	693.59	708.82	737.98	974.58
Income Tax Expense	114.45	117.07	121.88	130.43	122.31	188.43
Earnings From Continuing Operations	592.86	588.29	571.71	578.39	615.68	786.15
Minority Interest in Earnings	-87.87	-86.34	-70.7	-77.95	-67.41	-83.34
Net Income	504.99	501.95	501	500.44	548.27	702.81
Net Income to Common	504.99	501.95	501	500.44	548.27	702.81
Net Income Growth	-1.31%	0.19%	0.11%	-8.72%	-21.99%	42.67%
Shares Outstanding (Basic)	446	447	447	447	449	449
Shares Outstanding (Diluted)	449	447	447	447	449	449
Shares Change (YoY)	0.16%	-0.01%	0.11%	-0.50%	-0.09%	0.32%
EPS (Basic)	1.13	1.12	1.12	1.12	1.22	1.56
EPS (Diluted)	1.12	1.12	1.12	1.12	1.22	1.56
EPS Growth	-1.66%	0%	-	-8.26%	-21.92%	42.21%
Free Cash Flow	587.96	564.52	430.88	332.13	248.52	572.09
Free Cash Flow Per Share	1.31	1.26	0.96	0.74	0.55	1.27
Dividend Per Share	-	-	0.450	0.311	-	-
Dividend Growth	-	-	44.70%	-	-	-
Gross Margin	38.56%	38.63%	38.51%	38.53%	40.81%	46.06%
Operating Margin	23.75%	23.81%	24.04%	24.39%	27.03%	33.42%
Profit Margin	17.27%	17.23%	17.43%	17.58%	20.17%	25.27%
Free Cash Flow Margin	20.11%	19.38%	14.99%	11.67%	9.14%	20.57%
EBITDA	776.5	777.12	779.56	779.55	816.57	1,001
EBITDA Margin	26.56%	26.68%	27.13%	27.39%	30.04%	35.99%
D&A For EBITDA	82.09	83.4	88.63	85.21	81.6	71.43
EBIT	694.42	693.72	690.92	694.35	734.97	929.37
EBIT Margin	23.75%	23.81%	24.04%	24.39%	27.03%	33.42%
Effective Tax Rate	16.18%	16.60%	17.57%	18.40%	16.57%	19.34%
Revenue as Reported	2,924	2,913	2,874	2,847	2,719	2,781
Advertising Expenses	-	24.91	22.93	21.54	23.41	20.87

Source: S&P Global Market Intelligence. Standard template. Financial Sources.